CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+15.27%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$17.3B
AUM Growth
+$17.3B
(+8.6%)
Cap. Flow
-$338M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
32.07%
Holding
736
New
61
Increased
219
Reduced
340
Closed
55
Top Buys
| 1 |
Broadcom
AVGO
|
$108M |
| 2 |
Abbott
ABT
|
$55.5M |
| 3 |
Exelon
EXC
|
$45.5M |
| 4 |
Boston Scientific
BSX
|
$45.2M |
| 5 |
AbbVie
ABBV
|
$32.4M |
Top Sells
| 1 |
Tesla
TSLA
|
$84.8M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$58.7M |
| 3 |
CrowdStrike
CRWD
|
$53.7M |
| 4 |
Merck
MRK
|
$39.1M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$38.2M |
Sector Composition
| 1 | Technology | 36.26% |
| 2 | Healthcare | 22.75% |
| 3 | Financials | 10.33% |
| 4 | Consumer Discretionary | 7.75% |
| 5 | Industrials | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
PTC
PTC
$25.6B
| $55.4M | 0.32% |
321,208
-53,770
| -14% | -$9.27M |
|
77
Pfizer
PFE
$142B
| $54.3M | 0.31% |
2,240,955
+581,355
| +35% | +$14.1M |
|
78
American Water Works
AWK
$28B
| $53.9M | 0.31% |
387,482
+1,617
| +0.4% | +$225K |
|
79
Costco
COST
$418B
| $52.3M | 0.3% |
52,866
-3,487
| -6% | -$3.45M |
|
|
80
Exelon
EXC
$44.1B
| $52.3M | 0.3% |
1,203,699
+1,047,459
| +670% | +$45.5M |
|
81
Applied Materials
AMAT
$126B
| $51.5M | 0.3% |
281,482
-68,359
| -20% | -$12.5M |
|
82
eBay
EBAY
$41.4B
| $50.7M | 0.29% |
680,847
-115,988
| -15% | -$8.64M |
|
83
Coca-Cola
KO
$297B
| $50M | 0.29% |
706,293
+207,955
| +42% | +$14.7M |
|
84
Zscaler
ZS
$42.7B
| $49.7M | 0.29% |
158,310
+13,217
| +9% | +$4.15M |
|
85
Walt Disney
DIS
$213B
| $48.9M | 0.28% |
394,172
+70,392
| +22% | +$8.73M |
|
86
Quest Diagnostics
DGX
$20.3B
| $47.7M | 0.28% |
265,771
-12,885
| -5% | -$2.31M |
|
87
Bristol-Myers Squibb
BMY
$96B
| $46.4M | 0.27% |
1,002,904
-92,461
| -8% | -$4.28M |
|
88
Synopsys
SNPS
$112B
| $45.8M | 0.26% |
89,418
+13,051
| +17% | +$6.69M |
|
89
Johnson & Johnson
JNJ
$427B
| $45.2M | 0.26% |
295,670
-3,444
| -1% | -$526K |
|
90
Synchrony
SYF
$28.4B
| $44.4M | 0.26% |
665,006
+72,128
| +12% | +$4.81M |
|
91
Insmed
INSM
$28.8B
| $44.2M | 0.25% |
438,688
-16,720
| -4% | -$1.68M |
|
92
Idexx Laboratories
IDXX
$51.8B
| $42.4M | 0.24% |
79,028
-3,163
| -4% | -$1.7M |
|
93
Analog Devices
ADI
$124B
| $42.3M | 0.24% |
177,580
+73,385
| +70% | +$17.5M |
|
94
PepsiCo
PEP
$206B
| $41.5M | 0.24% |
314,457
-67,448
| -18% | -$8.91M |
|
95
Parker-Hannifin
PH
$96.2B
| $41.1M | 0.24% |
58,911
-790
| -1% | -$552K |
|
96
Credo Technology Group
CRDO
$21.5B
| $38.8M | 0.22% |
418,771
-309,754
| -43% | -$28.7M |
|
|
97
CrowdStrike
CRWD
$104B
| $38M | 0.22% |
74,658
-105,384
| -59% | -$53.7M |
|
98
Neurocrine Biosciences
NBIX
$13.8B
| $37.5M | 0.22% |
298,551
-32,289
| -10% | -$4.06M |
|
99
Fiserv
FI
$75.1B
| $37.1M | 0.21% |
215,437
+4,231
| +2% | +$729K |
|
100
CME Group
CME
$96B
| $36.5M | 0.21% |
132,581
+49,537
| +60% | +$13.7M |
|